Penn faculty members named Hastings Center Fellows for their work in bioethical fields thedp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedp.com Daily Mail and Mail on Sunday newspapers.
Penn researchers weigh in on the regulatory and scientific efforts to track COVID-19 vaccines. Between December 2020 and February 2021, three drugmakers received Emergency Use Authorizations to distribute COVID-19 vaccines. The next step is a biologics license application the technical name for full approval a process Pfizer and Moderna have already begun. Experts from Penn are keeping a close eye on these regulatory steps, as well as the reporting mechanisms involved in assessing vaccine safety. The outlook thus far seems promising. (Image: Daniel Schlud)
The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic disease, with real-world data bearing out that success. The other vaccine currently available in the U.S., produced by Janssen, uses a viral
The study, published in the
American Journal of Bioethics, examined the ethics of paying participants to take part in so-called Human Infection Challenge Studies (HICS).
The authors of the study believe that using HICS for a disease that can be fatal and currently lacks a cure is ethically controversial. Part of that controversy has to do with whether participants should be compensated for indulging in such a risky matter and how payment might affect their consent.
The international research team from the United Kingdom (UK), United States (US), and Canada, who carried out the study, does not endorse the use of HICS for Covid-19. But if HICS proceeds, their findings reflect that not only should participants be paid, but their payment should be substantial .
Are Healthy People Infected With Covid-19 for Clinical Trials Being Paid? by Hannah Joy on February 6, 2021 at 1:17 PM
Healthy people volunteering to be infected with SARS-CoV-2 should receive a substantial amount, as they are helping scientists to better understand how to tackle the virus.
Those are the findings of a new peer-reviewed study published in the American Journal of Bioethics, which has assessed the ethics of paying participants to take part in so-called Human Infection Challenge Studies (HICS).
Over the past few months there has been vast media coverage and discussion about the first COVID-19 HICS in the world, planned to begin in the UK later this year. This type of study can be particularly valuable for testing vaccines and can speed up the development of new vaccines.
Healthy people infected with COVID-19 for sake of science should be paid, experts suggest ANI | Updated: Feb 05, 2021 21:43 IST
Washington [US], February 5 (ANI): Multidisciplinary team of international experts suggests that healthy people volunteering to be infected with SARS-CoV-2, in order to help scientists better understand how to tackle the virus, should receive payment - if it is determined that these studies are otherwise ethical to proceed.
Those are the findings of a new peer-reviewed study published in the American Journal of Bioethics, which has assessed the ethics of paying participants to take part in so-called Human Infection Challenge Studies (HICS).
Over the past few months, there has been vast media coverage and discussion about the first COVID-19 HICS in the world planned to begin in the UK later this year. This type of study can be particularly valuable for testing vaccines and can speed up the development of new vaccin